Thierry Delair
Corporate Officer/Principal bei Defymed SAS
Profil
Thierry Delair is currently a Professor at Université Claude Bernard Lyon 1 and a Member-Scientific Board at Defymed SAS.
He previously worked as a Principal at bioMérieux SA.
Aktive Positionen von Thierry Delair
| Unternehmen | Position | Beginn |
|---|---|---|
Defymed SAS
 Defymed SAS BiotechnologyHealth Technology Defymed SAS develops and markets implantable bio-artificial medical devices for therapeutic applications. Its products include MailPan, a bioartificial pancreas; and ExOlin, a physiological insulin delivery device. The company was founded by Severine Sigrist in March 2011 and is headquartered in Strasbourg, France. | Corporate Officer/Principal | - |
| Université Claude Bernard Lyon 1 | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Thierry Delair
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMÉRIEUX | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Defymed SAS
Defymed SAS BiotechnologyHealth Technology Defymed SAS develops and markets implantable bio-artificial medical devices for therapeutic applications. Its products include MailPan, a bioartificial pancreas; and ExOlin, a physiological insulin delivery device. The company was founded by Severine Sigrist in March 2011 and is headquartered in Strasbourg, France. | Health Technology |
